Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(31 sites)
United States
Stanford University, Redwood City, California _University of California, San Francisco, San Francisco, California University of California at San Francisco, San Francisco, California University of Colorado Anschutz Medical Campus, Aurora, Colorado St Mary's University/Tenent Health, West Palm Beach, Florida Emory University School of Medicine, Atlanta, Georgia Indiana University School of Medicine - Methodist Hospital, Indianapolis, Indiana Indiana University/Eskenazi Health, Indianapolis, Indiana University of Kentucky, Lexington, Kentucky LSU Health Sciences, New Orleans, Louisiana University of Maryland , MD Department of Orthopaedics, Baltimore, Maryland Walter Reed Military Medical Center, Bethesda, Maryland Harvard/Mass General/Brigham Hospitals, Boston, Massachusetts Hennepin County Medical Center / Minneapolis, Minneapolis, Minnesota University of Mississippi Medical Center, Jackson, Mississippi Dartmouth Hitchcock, Lebanon, New Hampshire Jamaica Hospital Medical Center, Jamaica, New York University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Atrium Health Carolinas Medical Center, Charlotte, North Carolina Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina METROHealth, Cleveland, Ohio Ohio State University Wexner Medical Center, Columbus, Ohio University of Oklahoma College of Medicine, Oklahoma City, Oklahoma Temple University, Philadelphia, Pennsylvania Brown University/Rhode Island Hospital, Providence, Rhode Island Rhode Island Hospital/Brown University, Providence, Rhode Island Vanderbilt University Medical Center, Nashville, Tennessee University of Texas Health Science Center - Houston, Houston, Texas University of Virginia, Charlottesville, Virginia Inova Fairfax MEdical Campus, Falls Church, Virginia Virginia Commonwealth University Medical Center, Richmond, Virginia